Literature DB >> 30064067

Investigating owner use of dietary supplements in dogs with idiopathic epilepsy.

Benjamin Andreas Berk1, Rowena Mary Anne Packer2, Tsz Hong Law2, Holger Andreas Volk2.   

Abstract

Epilepsy is the most common chronic neurological disorder in dogs. Some diets have been shown to have a positive impact upon the seizure activity in dogs with idiopathic epilepsy (IE), while other diets and dietary supplements (DS), although marketed as providing health benefits, lack conclusive scientific evidence on their actual beneficial effects. A web-based owner questionnaire was designed to assess how and why owners of dogs with IE use different dietary regimes and DS. The study cohort, with 297 valid responses, consisted mainly of pure-breed (82.5%) male neutered (52.9%) dogs. Over two-thirds of owners (67.7%) changed their dog's diet after their dog received a diagnosis of IE. Nearly half of the owners (45.8%) reported giving DS, the most common being coconut oil or derived medium-chain triglyceride oil (71.3%). Some owner justifications of DS use included improvement of seizure frequency (88.2%), seizure severity (61.8%) and protection from potential drug side effects (62.5%). Many owners give DS to their dog with IE. The pharmacokinetic properties of anti-epileptic drugs, such as efficacy, absorption and clearance can be influenced by other medications, diets and possibly by DS. We propose that use of DS should be considered and monitored by veterinary surgeons in epilepsy management.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diet; Dietary supplement; Epilepsy; Neurodietetics; Seizure; Veterinary neurology

Mesh:

Year:  2018        PMID: 30064067     DOI: 10.1016/j.rvsc.2018.07.004

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  7 in total

1.  Cross Sectional Survey of Canine Idiopathic Epilepsy Management in Primary Care in the United Kingdom.

Authors:  Sebastian Griffin; Fabio Stabile; Luisa De Risio
Journal:  Front Vet Sci       Date:  2022-06-20

2.  Evaluation of fecal Lactobacillus populations in dogs with idiopathic epilepsy: a pilot study.

Authors:  Karen R Muñana; Megan E Jacob; Benjamin J Callahan
Journal:  Anim Microbiome       Date:  2020-05-11

3.  A double-blinded randomised dietary supplement crossover trial design to investigate the short-term influence of medium chain fatty acid (MCT) supplement on canine idiopathic epilepsy: study protocol.

Authors:  Benjamin Andreas Berk; Rowena Mary Anne Packer; Tsz Hong Law; Annette Wessmann; Andrea Bathen-Nöthen; Tarja Susanna Jokinen; Anna Knebel; Andrea Tipold; Ludovic Pelligand; Holger Andreas Volk
Journal:  BMC Vet Res       Date:  2019-05-30       Impact factor: 2.741

4.  Behavioral Interventions as an Adjunctive Treatment for Canine Epilepsy: A Missing Part of the Epilepsy Management Toolkit?

Authors:  Rowena M A Packer; Sarah L Hobbs; Emily J Blackwell
Journal:  Front Vet Sci       Date:  2019-01-28

5.  A multicenter randomized controlled trial of medium-chain triglyceride dietary supplementation on epilepsy in dogs.

Authors:  Benjamin A Berk; Tsz H Law; Rowena M A Packer; Annette Wessmann; Andrea Bathen-Nöthen; Tarja S Jokinen; Anna Knebel; Andrea Tipold; Ludovic Pelligand; Zoe Meads; Holger A Volk
Journal:  J Vet Intern Med       Date:  2020-04-15       Impact factor: 3.333

6.  Impact of canine epilepsy on judgement and attention biases.

Authors:  Sarah L Hobbs; Tsz Hong Law; Holger A Volk; Chantal Younis; Rachel A Casey; Rowena M A Packer
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

7.  Efficacy of medium chain triglyceride oil dietary supplementation in reducing seizure frequency in dogs with idiopathic epilepsy without cluster seizures: a non-blinded, prospective clinical trial.

Authors:  Jenifer Molina; Clementine Jean-Philippe; Lisa Conboy; Sonia Añor; Cristian de la Fuente; Marcin Adam Wrzosek; Andrea Spycher; Eva Luchsinger; Bettina Wenger-Riggenbach; Patricia Montoliu; Gualtiero Gandini; Marika Menchetti; João Carlos Ribeiro; Artur Varejão; Antonio Ferreira; Brian Zanghi; Holger Andreas Volk
Journal:  Vet Rec       Date:  2020-06-12       Impact factor: 2.695

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.